Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Anti-cancer drug design

Results: 1-25/380

Authors: Pettit, GR Orr, B Ducki, S
Citation: Gr. Pettit et al., Antineoplastic agents 453. Synthesis of pancratistatin prodrugs, ANTI-CAN DR, 15(6), 2000, pp. 389-395

Authors: Pettit, GR Minardi, MD Boyd, MR Pettit, RK
Citation: Gr. Pettit et al., Antineoplastic agents 463. Synthesis of combretastatin A-3 diphosphate prodrugs, ANTI-CAN DR, 15(6), 2000, pp. 397-403

Authors: Wang, ZM Lin, HK Zhu, SR Liu, TF Zhou, ZF Chen, YT
Citation: Zm. Wang et al., Synthesis, characterization and cytotoxicity of lanthanum(III) complexes with novel 1,10-phenanthroline-2,9-bis-alpha-amino acid conjugates, ANTI-CAN DR, 15(6), 2000, pp. 405-411

Authors: Arimondo, P Boukarim, C Bailly, C Dauzonne, D Monneret, C
Citation: P. Arimondo et al., Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity, ANTI-CAN DR, 15(6), 2000, pp. 413-421

Authors: Geiger, T Husken, D Weiler, J Natt, F Woods-Cook, KA Hall, J Fabbro, D
Citation: T. Geiger et al., Consequences of the inhibition of Hdm2 expression in human osteosarcoma cells using antisense oligonucleotides, ANTI-CAN DR, 15(6), 2000, pp. 423-430

Authors: Ross, SA Carr, CA Briet, JW Lowe, G
Citation: Sa. Ross et al., Transfer of 4 '-chloro-2,2 ': 6 ',2 ''-terpyridine platinum(II) between human serum albumin, glutathione and other thiolate ligands. A possible selective natural transport mechanism for the delivery of platinum(II) drugs to tumour cells, ANTI-CAN DR, 15(6), 2000, pp. 431-439

Authors: Wu, JH Batist, G Zamir, LO
Citation: Jh. Wu et al., A model for the interaction of paclitaxel with the Bcl-2 loop domain: a chemical approach to induce conformation-dependent phosphorylation, ANTI-CAN DR, 15(6), 2000, pp. 441-446

Authors: Andreani, A Cavalli, A Granaiola, M Leoni, A Locatelli, A Morigi, R Rambaldi, M Recanatini, M Garnier, M Meijer, L
Citation: A. Andreani et al., Imidazo[2,1-b]thiazolylmethylene- and indolylmethylene-2-indolinones: a new class of cyclin-dependent kinase inhibitors. Design, synthesis, and CDK1/cyclin B inhibition, ANTI-CAN DR, 15(6), 2000, pp. 447-452

Authors: Spicer, JA Denny, WA
Citation: Ja. Spicer et Wa. Denny, Synthesis of tetracyclic benzodioxins as potential antitumour agents, ANTI-CAN DR, 15(6), 2000, pp. 453-458

Authors: Fahrig, R Steinkamp-Zucht, A Schaefer, A
Citation: R. Fahrig et al., Prevention of adriamycin-induced mdr1 gene amplification and expression inmouse leukemia cells by simultaneous treatment with the anti-recombinogen bromovinyldeoxyuridine, ANTI-CAN DR, 15(5), 2000, pp. 307-312

Authors: Wheate, NJ Webster, LK Brodie, CR Collins, JG
Citation: Nj. Wheate et al., Synthesis, DNA binding and cytotoxicity of isohelical DNA groove binding platinum complexes, ANTI-CAN DR, 15(5), 2000, pp. 313-322

Authors: Engman, L Kanda, T Gallegos, A Williams, R Powis, G
Citation: L. Engman et al., Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells, ANTI-CAN DR, 15(5), 2000, pp. 323-330

Authors: Karawajew, L Glibin, EN Maleev, VY Czerwony, G Dorken, B Davies, DB Veselkov, AN
Citation: L. Karawajew et al., Role of crown-like side chains in the biological activity of substituted-phenoxazone drugs, ANTI-CAN DR, 15(5), 2000, pp. 331-338

Authors: Deady, LW Rodemann, T Finlay, GJ Baguley, BC Denny, WA
Citation: Lw. Deady et al., Synthesis and cytotoxic activity of carboxamide derivatives of benzimidazo[2,1-a]isoquinoline and pyrido[3 ',2 ': 4,5]imidazo[2,1-a]isoquinoline, ANTI-CAN DR, 15(5), 2000, pp. 339-346

Authors: Di Francesco, AM Hargreaves, RHJ Wallace, TW Mayalarp, SP Hazratis, A Hartley, JA Butler, J
Citation: Am. Di Francesco et al., The abnormal cytotoxicities of 2,5-diaziridinyl-1,4-benzoquinone-3-phenyl esters, ANTI-CAN DR, 15(5), 2000, pp. 347-359

Authors: Pettit, GR Lippert, JW Boyd, MR Verdier-Pinard, P Hamel, E
Citation: Gr. Pettit et al., Antineoplastic agents 442. Synthesis and biological activities of dioxostatin, ANTI-CAN DR, 15(5), 2000, pp. 361-371

Authors: Cutts, SM Parker, BS Swift, LP Kimura, K Phillips, DR
Citation: Sm. Cutts et al., Structural requirements for the formation of anthracycline-DNA adducts, ANTI-CAN DR, 15(5), 2000, pp. 373-386

Authors: Lant, NJ McKeown, P Kelland, LR Rogers, PM Robins, DJ
Citation: Nj. Lant et al., Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol (vol 15, pg 295, 2000), ANTI-CAN DR, 15(5), 2000, pp. 387-387

Authors: Umezawa, K Ariga, A Matsumoto, N
Citation: K. Umezawa et al., Review - Naturally occurring and synthetic inhibitors of NF-kappa B functions, ANTI-CAN DR, 15(4), 2000, pp. 239-244

Authors: Turner, PR Denny, WA Ferguson, LR
Citation: Pr. Turner et al., Role of DNA minor groove alkylation and DNA cross-linking in the cytotoxicity of polybenzamide mustards, ANTI-CAN DR, 15(4), 2000, pp. 245-253

Authors: Krishnan, P Bastow, KF
Citation: P. Krishnan et Kf. Bastow, The 9-position in berberine analogs is an important determinant of DNA topoisomerase II inhibition, ANTI-CAN DR, 15(4), 2000, pp. 255-264

Authors: Singh, AK Lown, JW
Citation: Ak. Singh et Jw. Lown, Design, synthesis and antitumor cytotoxicity of novel bis-benzimidazoles, ANTI-CAN DR, 15(4), 2000, pp. 265-275

Authors: Gedda, L Ghaneolhosseini, H Nilsson, P Nyholm, K Pettersson, J Sjoberg, S Carlsson, J
Citation: L. Gedda et al., The influence of lipophilicity on binding of boronated DNA-intercalating compounds in human glioma spheroids, ANTI-CAN DR, 15(4), 2000, pp. 277-286

Authors: Wu, T Xu, SJ Shen, JQ Song, AM Chen, S Zhang, MH Shen, T
Citation: T. Wu et al., New potential photodynamic therapeutic anti-cancer agents: synthesis and characterization of demethoxy amino-substituted hypocrellins, ANTI-CAN DR, 15(4), 2000, pp. 287-293

Authors: Lant, NJ McKeown, P Kelland, LR Rogers, PM Robins, DJ
Citation: Nj. Lant et al., Synthesis and antimelanoma activity of analogues of N-acetyl-4-S-cysteaminylphenol, ANTI-CAN DR, 15(4), 2000, pp. 295-302
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>